Consortium of experts
The Nanovaccine Institute is a consortium of 79 researchers at 24 universities, research institutes, national laboratories, and companies, founded and coordinated by Iowa State University.
Interdisciplinary research
Our research is a transdisciplinary merger of expertise in immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. We are developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, antimicrobial resistance, cancer, aging, and animal health. Our vision is that nanovaccines and nanotherapeutics will revolutionize how we prevent and treat disease.
Revolutionizing how we prevent and treat disease
6 6
Focus Areas 79 79
Researchers 24 24
Institutions NANOVACCINE INSTITUTE RESEARCHER PROFILE
Dr. Surya Mallapragada, Iowa State University